Skip to main content
SpringerLink
Log in

Combination therapy in mice: what can we learn that may be useful for understanding rheumatoid arthritis?

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Banerjee S, Wei BY, Hillman K, Luthra HS, David CS (1988) Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody. J Immunol 141:1150

    Google Scholar 

  2. Benjamin RJ, Waldmann H (1986) Induction of tolerance by monoclonal antibody therapy. Nature 320: 449

    Google Scholar 

  3. Boissier MC, Feng XZ, Carlioz A, Roudier R, Fournier C (1987) Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis. Anti Rheum Dis 46:691

    Google Scholar 

  4. Brahn E, Trentham DE (1984) Effect of antithymocyte serum on collagen arthritis in rats: evidence that T cells are involved in its pathogenesis. Cell Immunol 86:421

    Google Scholar 

  5. Brahn E, Peacock DJ, Banquerigo ML (1991) Suppression of collagen-induced arthritis by combination cyclosporin A and methotrexate therapy. Arthritis Rheum 34: 1282

    Google Scholar 

  6. Burmester GR, Yu DT, Irani AM, Kunkel HG, Winchester RJ (1981) Ia+T cells in synovial fluid and tissues of patients with rheumatoid arthritis. Arthritis Rheum 24:1370

    Google Scholar 

  7. Reference deleted

  8. Calabrese LH, Wilke WS, Perkins AD, Tubbs RR (1989) Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjogren's syndrome. Arthritis Rheum 32:1453

    Google Scholar 

  9. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H (1984) Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312: 548

    Google Scholar 

  10. Cooper SM, Sriram S, Ranges GE (1988) Suppression of murine collagen-induced arthritis with monoclonal anti-la antibodies and augmentation with IFN-gamma. J Immunol 141:1958

    Google Scholar 

  11. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B (1980) Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283: 666

    Google Scholar 

  12. Daikh DI, Finck BK, Linsley PS, Hollenbaugh D, Wofsy D (1997) Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J Immunol 159:3104

    Google Scholar 

  13. Doncarli A, Stasiuk LM, Fournier C, Abehsira-Amar O (1997) Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis. Eur J Immunol 27: 1451

    Google Scholar 

  14. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328

    Google Scholar 

  15. Elliott MJ, Maim RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Ghrayeb J, Woody JN (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumour necrosis factor α. Arthritis Rheum 36:1681

    Google Scholar 

  16. Elliott MJ, Maim RN, Feldmann M, Kalden JR, Antoni C, Smollen JS, Leeb B, Breedfeld FC, Macfarlane JD, Bijl H, Woody JN (1994) Treatment with a chimaeric monoclonal antibody to tumour necrosis factor α suppresses disease activity in rheumatoid arthritis: results of a multi-centre, randomised, double blind trial. Lancet 344: 1105

    Google Scholar 

  17. Elliott MJ, Maim RN, Feldmann M, Long-Fox A, Charles P, Bijl H, Woody JN (1994) Repeated therapy with a monoclonal antibody to tumour necrosis factor α in patients with rheumatoid arthritis. Lancet 344: 1125

    Google Scholar 

  18. Emery P (1997) Prognosis in inflammatory arthritis: the value of HLA genotyping and the oncological analogy. J Rheumatol 24: 1436

    Google Scholar 

  19. Feldmann M, Brennan FM, Abney ER, Hales A, Chemajovsky Y, Katsikis P, Corcoran A, Haworth C, Cope A, Gibbons D, Chu CQ, Field M, Deleuran B, Williams RO, Maim RN (1994) Are imbalances in cytokine function of importance in the pathogenesis of rheumatoid arthritis? In: Davies ME, Dingle JT (eds) Immunopharmacology of joints and connective tissue. Academic Press, London, pp 119–128

    Google Scholar 

  20. Finck BK, Chan B, Wofsy D (1994) Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest 94: 585

    Google Scholar 

  21. Finck BK, Linsley PS, Wofsy D (1994) Treatment of murine lupus with CTLA4Ig. Science 265:1225

    Google Scholar 

  22. Firestein GS, Zvaifler NJ (1990) How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33:768

    Google Scholar 

  23. Galfre G, Milstein C, Wright B (1979) Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG. Nature 277: 131

    Google Scholar 

  24. Genain CP, Roberts T, Davis RL, Nguyen MH, Uccelli A, Faulds D, Li Y, Hedgpeth J, Hauser SL (1995) Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc Natl Acad Sci USA 92: 3601

    Google Scholar 

  25. Goldschmidt TJ, Holmdahl R (1991) Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis: suppression of arthritis without reduction of anti-type II collagen autoantibody levels. Eur J Immunol 21:1327

    Google Scholar 

  26. Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30: 1205

    Google Scholar 

  27. Griggs ND, Agersborg SS, Noelle RJ, Ledbetter JA, Linsley PS, Tung KS (1996) The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J Exp Med 183: 801

    Google Scholar 

  28. Holmdahl R, Jansson L, Larsson E, Rubin K, Klareskog L (1986) Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum 29: 106

    Google Scholar 

  29. Holmdahl R, Andersson M, Enander I, Goldschmidt T, Jansson L, Larsson P, Mo J, Nordling C, Klareskog L (1988) Nature of the type II collagen autoimmunity in mice susceptible to collagen-induced arthritis. Int Rev Immunol 4: 49

    Google Scholar 

  30. Holmdahl R, Andersson ME, Goldschmidt TJ, Jansson L, Karlsson M, Malmström V, Mo J (1989) Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity. APMIS 97:575

    Google Scholar 

  31. Hom JT, Butler LD, Riedl PE, Bendele AM (1988) The progression of the inflammation in established collagen-induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities. Eur J Immunol 18: 881

    Google Scholar 

  32. Horsfall AC, Butler DM, Marinova L, Warden PJ, Williams RO, Maim RN, Feldmann M (1997) Suppression of collagen-induced arthritis by continuous administration of IL-4. J Immunol 159:5687

    Google Scholar 

  33. Jabs DA, Kuppers RC, Saboori AM, Burek CL, Enger C, Lee B (1994) Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice. Cell Immunol 154:66

    Google Scholar 

  34. Joosten LA, Lubberts E, Durez P, Helsen MM, Jacobs MJ, Goldman M, Van den Berg WB (1997) Role of interleukin-4 and interleukin-10 in murine collagen- induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 40: 249

    Google Scholar 

  35. Kasama T, Stricter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL (1995) Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 95: 2868

    Google Scholar 

  36. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn, KJ, Persson TC (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434

    Google Scholar 

  37. Maeda T, Saikawa I, Hotokebuchi T, Sugioka Y, Eto M, Murakami Y (1994) Exacerbation of established collagen-induced arthritis in mice treated with an anti-T cell receptor antibody. Arthritis Rheum 37: 406

    Google Scholar 

  38. Maini RN, Elliott MJ, Brennan FM, Williams RO, Chu CQ, Paleolog E, Charles PJ, Taylor PC, Feldmann M (1995) Monoclonal anti-TNFα antibody as a probe of pathogenesis and therapy of rheumatoid arthritis. Immunol Rev 144:195

    Google Scholar 

  39. Maini RN, Breedveld FC, Kalden JR, Smolen IS, Davis D, Macfarlane JD, Antoni C, Leeb B, Elliott MJ, Woody JN, Schaible TF, Feldmann M (1997) Low dose methotrexate (MTX) suppresses anti-globulin responses and potentiates efficacy of a chimeric monoclonal anti-TNFα antibody (cA2) given repeatedly in rheumatoid arthritis (RA). Arthritis Rheum 40 [Suppl]: S 126

    Google Scholar 

  40. Malfait A-M, Butler DM, Presky DH, Maim RN, Brennan FM, Feldmann M (1998) Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis. Clin Exp Immunol 111: 377

    Google Scholar 

  41. Mauri C, Williams RO, Walmsley M, Feldmann M (1996) Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 26: 1511

    Google Scholar 

  42. Mauri C, Chu CQ, Woodrow D, Mori L, Londei M (1997) Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody. J Immunol 159:5032

    Google Scholar 

  43. Mohan C, Shi Y, Laman JD, Datta SK (1995) Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154: 1470

    Google Scholar 

  44. Moreland LW, Heck LW, Koopman WJ (1997) Biologic agents for treating rheumatoid arthritis. Arthritis Rheum 40: 397

    Google Scholar 

  45. Nguyen DT, Eskandai MK, DeForge LE, Raiford CL, Strieter RM, Kunkel SL, Remick DG (1990) Cyclosporin A modulation of tumor necrosis factor gene expression and effects in vitro and in vivo. J Immunol 144:3822

    Google Scholar 

  46. Noelle RJ (1998) CD40 and its ligand in cell-mediated immunity. Agents Actions [Suppl] 49: 17

    Google Scholar 

  47. O'Keefe SJ, Tamura J, Kincaid RL, Tocci MJ, O'Neill EA (1992) FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357: 692

    Google Scholar 

  48. Oliver SJ, Cheng TP, Banquerigo ML, Brahn E (1995) Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF). Cell Immunol 166:196

    Google Scholar 

  49. Paulus HE, Machleder HI, Levine S, Yu DT, MacDonald NS (1977) Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage. Arthritis Rheum 20: 1249

    Google Scholar 

  50. Persson S, Mikulowska A, Narula S, O'Garra A, Holmdahl R (1996) Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 44:607

    Google Scholar 

  51. Piguet PF, Grau GE, Vesin C, Loetscher H, Gentz R, Lesslauer W (1992) Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology 77: 510

    Google Scholar 

  52. Qin S, Cobbold S, Tighe H, Benjamin R, Waldmann H (1987) CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur J Immunol 17: 1159

    Google Scholar 

  53. Ranges GE, Sriram S, Cooper SM (1985) Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med 162:1105

    Google Scholar 

  54. Rep MIL, Oosten BW van, Roos MT, Ader HJ, Polman CH, Lier RA van (1997) Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting Th1 cells in humans. J Clin Invest 99: 2225

    Google Scholar 

  55. Ross SE, Williams RO, Mason LJ, Mauri C, Marinova-Mutafchieva L, Malfait A-M, Maim RN, Feldmann M (1997) Suppression of TNF-α expression, inhibition of Thl activity, and amelioration of collagen-induced arthritis by rolipram. J Immunol 159:6253

    Google Scholar 

  56. Sheehan KC, Ruddle NH, Schreiber RD (1989) Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 142: 3884

    Google Scholar 

  57. Sommer N, Loschmann PA, Northoff GH, Weller M, Steinbrecher A, Lichtenfels R, Meyermann R, Riethmuller A, Fontana A (1995) The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat Med 1: 244

    Google Scholar 

  58. Strober S, Kotzin B, Field E, Hoppe R, Myers B, Tanay A (1986) Treatment of autoimmune disease with total lymphoid irradiation. Cellular and humoral mechanisms. Ann N Y Acad Sci 475: 285

    Google Scholar 

  59. Taga T, Kishimoto T (1997) Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797

    Google Scholar 

  60. Tanaka Y, Otsuka T, Hotokebuchi T, Miyahara H, Nakashima H, Kuga S, Nemoto Y, Niiro H, Niho Y (1996) Effect of IL-10 on collagen-induced arthritis in mice. Inflamm Res 45:283

    Google Scholar 

  61. Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA (1992) Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type 11 arthritis in mice. Proc Natl Acad Sci USA 89:7375

    Google Scholar 

  62. Trentham DE (1982) Collagen arthritis as a relevant model for rheumatoid arthritis: evidence pro and con. Arthritis Rheum 25:911

    Google Scholar 

  63. Trentham DE, Townes AS, Kang AH (1977) Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 146: 857

    Google Scholar 

  64. Van Boxel JA, Paget SA (1975) Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med 293:517

    Google Scholar 

  65. Waldmann TA (1991) Monoclonal antibodies in diagnosis and therapy. Science 252:1657

    Google Scholar 

  66. Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maim RN, Feldmann M (1996) IL-10 inhibits progression of established collagen-induced arthritis. Arthritis Rheum 39:495

    Google Scholar 

  67. Webb LM, Walmsley ML, Feldmann M (1996) Prevention and amelioratrion of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur J Immunol 26:2320

    Google Scholar 

  68. Weyand CM, Hicok KC, Conn DL, Goronzy JJ (1992) The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117: 801

    Google Scholar 

  69. Wiederrecht G, Lam E, Hung S, Martin M, Sigal N (1993) The mechanism of action of FK-506 and cyclosporin A. Ann N Y Acad Sci 696: 9

    Google Scholar 

  70. Williams RO, Feldmann M, Maim RN (1992) Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 89: 9784

    Google Scholar 

  71. Williams RO, Mason LJ, Feldmann M, Maim RN (1994) Synergy between anti-CD4 and anti-TNF in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci USA 91:2762

    Google Scholar 

  72. Williams RO, Ghrayeb J, Feldmann M, Maim RN (1995) Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4. Immunology 84:433

    Google Scholar 

  73. Williams RO, Mauri C, Mason LJ, Marinova-Mutafchieva L, Ross SE, Feldmann M, Maim RN (1998) Therapeutic actions of cyclosporin and anti-TNFα in collagen-induced arthritis and effect of combination therapy. Arthritis Rheum (in press)

  74. Wooley PH, Luthra HS, Lafuse WP, Huse A, Stuart JM, David CS (1985) Type 11 collagen-induced arthritis in mice. III. Suppression of arthritis by using monoclonal and polyclonal anti-Ia antisera. J Immunol 134:2366

    Google Scholar 

  75. Yocum DE (1996) Cyclosporine, FK-506, rapamycin, and other immunomodulators. Rheum Dis Clin North Am 22: 133

    Google Scholar 

  76. Yoo TJ, Kim SY, Stuart JM, Floyd RA, Olson GA, Cremer MA, Kang AH (1988) Induction of arthritis in monkeys by immunization with type II collagen. J Exp Med 168:777

    Google Scholar 

  77. Yoshino S, Cleland LG (1992) Depletion of α/β T cells by a monoclonal antibody against the α/β T cell receptor suppresses established adjuvant arthritis, but not established collagen-induced arthritis in rats. J Exp Med 175: 907

    Google Scholar 

  78. Yoshino S, Cleland LG, Mayrhofer G (1991) Treatment of collagen-induced arthritis in rats with a monoclonal antibody against the alpha beta T cell antigen receptor. Arthritis Rheum 34: 1039

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kennedy Institute of Rheumatology, 1 Aspenlea Road, W6 8LH, London, UK

    Richard O. Williams

Authors
  1. Richard O. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, R.O. Combination therapy in mice: what can we learn that may be useful for understanding rheumatoid arthritis?. Springer Semin Immunopathol 20, 165–180 (1998). https://doi.org/10.1007/BF00832005

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00832005

Keywords

Search

Navigation